Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$255.51 - $362.11 $213,606 - $302,723
-836 Closed
0 $0
Q3 2021

Nov 03, 2021

BUY
$372.64 - $458.3 $7,825 - $9,624
21 Added 2.58%
836 $345,000
Q2 2021

Jul 21, 2021

BUY
$294.17 - $371.65 $239,748 - $302,894
815 New
815 $301,000
Q1 2021

May 13, 2021

SELL
$249.67 - $299.48 $203,481 - $244,076
-815 Closed
0 $0
Q4 2020

Jan 28, 2021

BUY
$222.0 - $252.62 $180,930 - $205,885
815 New
815 $203,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Wealth Advisory Solutions, LLC Portfolio

Follow Wealth Advisory Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Advisory Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Advisory Solutions, LLC with notifications on news.